Minimally Invasive Radical Trachelectomy

Minimally Invasive Radical Trachelectomy removes the cervix and upper vagina while preserving the uterus, offering select early-stage cervical cancer patients a chance at future pregnancy. Performed laparoscopically or robotically, it reduces recovery time but requires careful monitoring for recurrence or pregnancy complications.

Minimally Invasive Radical Hysterectomy 

Minimally Invasive Radical Hysterectomy treats early-stage cervical cancer by removing the cervix, uterus, upper vagina, and nearby lymph nodes through small incisions (laparoscopic/robotic). This approach reduces recovery time and complications compared to open surgery while maintaining equivalent oncologic outcomes for eligible patients

Loop Electrosurgical Excision Procedure (LEEP)

Loop Electrosurgical Excision Procedure (LEEP) uses a thin, electrified wire loop to remove precancerous cervical tissue (CIN) detected via Pap smear. Performed under local anesthesia, it prevents cancer development while preserving fertility, though may cause minor bleeding or cervical stenosis.

Bilateral Salpingo-Oophorectomy (BSO)

Bilateral Salpingo-Oophorectomy (BSO) removes both fallopian tubes and ovaries, often performed with hysterectomy for ovarian/endometrial cancer or BRCA+ risk reduction. While it eliminates hormone-driven cancers, it induces surgical menopause, requiring hormonal or non-hormonal management for side effects.

Pelvic Exenteration

Pelvic Exenteration is an aggressive salvage surgery for recurrent cervical or pelvic cancers, removing the uterus, cervix, ovaries, fallopian tubes, and often adjacent organs (bladder/rectum). Reconstructive procedures restore urinary/intestinal function, offering a curative option when radiation or chemotherapy fails.

Conization (or cold knife cone biopsy)

Conization (or cold knife cone biopsy) removes a cone-shaped wedge of cervical tissue to eliminate microscopic precancerous cells (CIN) or early-stage cancer. It preserves fertility but requires monitoring for recurrence or cervical incompetence in future pregnancies.

Brachytherapy

Brachytherapy delivers targeted radiation by placing radioactive seeds directly inside or near the tumor (e.g., cervix or prostate), maximizing cancer cell destruction while minimizing exposure to healthy tissues. Often used with external beam radiation, it shortens treatment time but may cause localized side effects like irritation. 

Targeted Therapy

Targeted Therapy uses IV drugs (e.g., monoclonal antibodies, kinase inhibitors) to attack specific molecules driving cancer growth, such as HER2 or VEGF. Unlike chemotherapy, it spares healthy cells but requires biomarker testing to confirm eligibility and monitor resistance.